Therefore, the objective of this study was to investigate the effect/mechanism of the action of apigenin in modulating IL-31 release in human mast cells (HMC-1) and in compound 48/80-induced itch in atopic dermatitis. This evidence concerns the gene IL31 and atopic eczema.